MedTrace Logo

Atrial Fibrillation Management in Congestive Heart Failure With Ablation

NCT00652522 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2019-02-04

No results posted yet for this study

Summary

It is the purpose of the study to show the benefit of the endocardial catheter ablation by pulmonary vein isolation in patients with persistent or longstanding persistent atrial fibrillation, low LVEF and requiring ICD or CRT-D therapy compared to the best medical treatment with antiarrhythmic drugs.

Conditions

Interventions

DEVICE

ICD/CRT implant

Implantation of a ICD/ CRT device if not yet implanted

PROCEDURE

AF ablation

Atrial Fibrillation ablation by pulmonary vein isolation

OTHER

Best Medical Treatment

Best medical treatment according to current guidelines for Management of Patients with Atrial Fibrillation and for Management of Chronic Heart Failure.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Karl-Heinz Kuck, Prof. · Asklepios Klinik St. Georg - Hamburg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2017-07-13
Completion
2017-07-13

Countries

  • Germany
  • Hungary
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652522 on ClinicalTrials.gov